Fortress Biotech Inc
F:CNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fortress Biotech Inc
F:CNB
|
US |
|
Daito Trust Construction Co Ltd
F:4D7
|
JP |
|
L
|
Linde PLC
XHAM:LIN
|
UK |
|
A
|
ADES Holding Company SJSC
SAU:2382
|
SA |
|
GitLab Inc
F:8K2
|
US |
|
B
|
Bank Central Asia Tbk PT
XMUN:BZG2
|
ID |
|
P
|
Pennantpark Investment Corp
F:12P
|
US |
|
Visteon Corp
NASDAQ:VC
|
US |
|
Hong Kong and China Gas Co Ltd
OTC:HOKCF
|
HK |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
C
|
Campbell Soup Co
DUS:CSC
|
US |
|
Austco Healthcare Ltd
ASX:AHC
|
AU |
Wall St Price Targets
CNB Price Targets Summary
Fortress Biotech Inc
According to Wall Street analysts, the average 1-year price target for CNB is 8.198 EUR with a low forecast of 8.117 EUR and a high forecast of 8.439 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CNB's stock price target?
Price Target
8.198
EUR
According to Wall Street analysts, the average 1-year price target for CNB is 8.198 EUR with a low forecast of 8.117 EUR and a high forecast of 8.439 EUR.
What is the Revenue forecast for Fortress Biotech Inc?
Projected CAGR
44%
The compound annual growth rate for Revenue over the next 2 years is 44%.
What is the Gross Profit forecast for Fortress Biotech Inc?
Projected CAGR
63%
The compound annual growth rate for Gross Profit over the next 2 years is 63%.
